Providence Capital Advisors’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.65M Buy
21,108
+6,029
+40% +$1.9M 1.01% 41
2026
Q1
$4.95M Buy
15,079
+141
+0.9% +$50.6K 0.81% 54
2025
Q4
$5.25M Buy
14,938
+96
+0.6% +$35K 0.88% 48
2025
Q3
$5.49M Buy
14,842
+409
+3% +$158K 0.95% 44
2025
Q2
$5.71M Buy
14,433
+472
+3% +$177K 1.05% 45
2025
Q1
$5.2M Buy
13,961
+346
+3% +$132K 1.08% 38
2024
Q4
$4.9M Buy
+13,615
New +$5.05M 0.99% 48
2023
Q4
– Sell
-11
Closed -$3.01K – 371
2023
Q3
$3.01K Buy
+11
New +$3.15K ﹤0.01% 281

Other funds holding SYK

Providence Capital Advisors's SYK Position: Q2 2026 in Review

Providence Capital Advisors increased its Stryker (SYK) stake by 40% in Q2 2026, buying an estimated $1.9M and bringing the position to 21,108 shares worth $6.65M. The position accounts for 1.01% of the portfolio, ranked #41.

Providence Capital Advisors first reported a position in SYK in Q3 2023 and has held it in 8 quarters since. 2,267 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Providence Capital Advisors held 21,108 shares of Stryker worth $6.65M as of Q2 2026.
  • Providence Capital Advisors bought 6,029 Stryker shares in Q2 2026, an estimated $1.9M.
  • Stryker made up 1.01% of Providence Capital Advisors's portfolio in Q2 2026, its #41 holding.
  • Providence Capital Advisors first reported a position in Stryker in Q3 2023 and has held it in 8 quarters since.
  • 2,267 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Providence Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.